BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 6228580)

  • 21. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
    Jayawardena AN; Murphy DB; Janeway CA; Gershon RK
    J Immunol; 1982 Jul; 129(1):377-81. PubMed ID: 6979570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
    J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice.
    Farrell JP; Muller I; Louis JA
    J Immunol; 1989 Mar; 142(6):2052-6. PubMed ID: 2784148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis.
    Titus RG; Milon G; Marchal G; Vassalli P; Cerottini JC; Louis JA
    Eur J Immunol; 1987 Oct; 17(10):1429-33. PubMed ID: 3119350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive transfer of delayed type hypersensitivity reactions specific for Leishmania major antigens to normal mice using murine T cell populations and clones generated in vitro.
    Lima GC; Engers HD; Louis JA
    Clin Exp Immunol; 1984 Jul; 57(1):130-8. PubMed ID: 6204797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP; Panosian CB; Wyler DJ
    J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.
    Howard JG; Nicklin S; Hale C; Liew FY
    J Immunol; 1982 Nov; 129(5):2206-12. PubMed ID: 7119442
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors influencing the host response to Leishmania mexicana.
    PĂ©rez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular interactions in the adoptive transfer of contact sensitivity: characterization of an antigen-nonspecific Vicia villosa-adherent T cell needed for adoptive transfer into naive recipients.
    Ptak W; Green DR; Flood P
    J Immunol; 1986 Sep; 137(6):1822-8. PubMed ID: 2943803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
    Van Loveren H; Kato K; Meade R; Green DR; Horowitz M; Ptak W; Askenase PW
    J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.
    Cher DJ; Mosmann TR
    J Immunol; 1987 Jun; 138(11):3688-94. PubMed ID: 2953788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis.
    Scott P; Natovitz P; Sher A
    J Immunol; 1986 Aug; 137(3):1017-21. PubMed ID: 3487581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P; Caspar P; Sher A
    J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Lightman S; Cobbold S; Waldmann H; Askonas BA
    Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine interstitial nephritis. III. The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-Id) T cell preferences by genes in Igh-1 and H-2K characterizes the cell-mediated potential for disease expression: susceptible mice provide a unique effector T cell repertoire in response to tubular antigen.
    Neilson EG; McCafferty E; Mann R; Michaud L; Clayman M
    J Immunol; 1985 Apr; 134(4):2375-82. PubMed ID: 2579142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
    Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
    Sewell WA; Munoz JJ; Scollay R; Vadas MA
    J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
    Dhaliwal JS; Liew FY
    Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.